Australia Gene Synthesis Research Use Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030
Description
Australia Gene Synthesis Research Use Market Overview
The Australia Gene Synthesis Research Use Market is valued at approximately USD 120 million, based on a five-year historical analysis of the broader Australia gene synthesis market and its research-focused demand profile. This growth is primarily driven by advancements in biotechnology, increasing research activities in genomics, and the rising demand for synthetic biology applications, in line with global gene synthesis trends. The market has seen a surge in investments from both public and private sectors in areas such as synthetic biology, regenerative medicine, and genomics infrastructure, enhancing the capabilities and accessibility of gene synthesis technologies in Australia. Key players in this market are concentrated in major cities such as Sydney, Melbourne, and Brisbane. These cities dominate due to their robust research infrastructure, presence of leading academic institutions, and a thriving biotech industry, including hubs around the University of Sydney, UNSW Sydney, University of Melbourne, Monash University, and major medical research institutes. The collaboration between universities, Cooperative Research Centres, and biotech firms in these regions fosters innovation and accelerates the development and use of gene synthesis technologies in applications such as synthetic biology, therapeutics, and diagnostics. In 2023, the Australian government implemented the National Biotechnology Strategy, which aims to support the growth of the biotechnology sector, including gene synthesis, with a focus on strengthening sovereign capability and industry–research translation. This strategy includes funding initiatives and regulatory and policy frameworks designed to enhance research capabilities and promote collaboration between industry and academia, ultimately driving advancements in gene synthesis technologies. In parallel, activities in gene synthesis and related DNA technologies are governed by instruments such as the Gene Technology Act 2000 administered by the Office of the Gene Technology Regulator, which establishes licensing, risk assessment, and containment requirements for dealings with genetically modified organisms relevant to synthetic and engineered genetic material used in research.
Australia Gene Synthesis Research Use Market Segmentation
By Product & Service: The product and service segmentation of the market includes various offerings that cater to the diverse needs of researchers and organizations involved in gene synthesis. The subsegments include gene synthesis services, gene synthesis kits & reagents, gene fragments & oligonucleotides for research, GMP-grade gene synthesis for clinical research use, and others. This structure aligns with typical global gene synthesis offerings, where custom gene synthesis services, oligonucleotide products, and associated reagents form the core of the commercial portfolio. Among these, gene synthesis services are the most dominant due to their tailored solutions, increasing complexity of synthetic constructs, and high demand from academic and commercial research entities seeking outsourced, high-accuracy synthesis and design support. By Application: The application segmentation encompasses various fields where gene synthesis is utilized, including basic genetic & molecular biology research, synthetic biology & genome engineering, cell & gene therapy research, vaccine, antibody & protein engineering research, agricultural & industrial biotechnology research, and others. These application clusters are consistent with how global markets characterize demand for gene synthesis across research and preclinical domains. The cell & gene therapy research segment is currently leading the market due to the increasing focus on personalized medicine, engineered cell therapies, and nucleic-acid-based therapeutics, which require complex custom gene constructs and vector designs.
Australia Gene Synthesis Research Use Market Market Opportunities
The Australia Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as Integrated DNA Technologies (IDT), Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Eurofins Genomics, Twist Bioscience Corporation, Codex DNA / Telesis Bio, Bioneer Corporation, ATUM, GENEWIZ (Azenta Life Sciences), Bio Basic Inc., LGC Biosearch Technologies, Jena Bioscience GmbH, Genetic Signatures Ltd (Australia), Starpharma Holdings Limited (Australia), Agilent Technologies Inc. contribute to innovation, geographic expansion, and service delivery in this space.
Integrated DNA Technologies (IDT)
1987 Coralville, Iowa, USA
Thermo Fisher Scientific Inc. 2006 Waltham, Massachusetts, USA
GenScript Biotech Corporation
2002 Nanjing, China
Eurofins Genomics
2000 Luxembourg City, Luxembourg
Twist Bioscience Corporation
2013 San Francisco, California, USA
Company
Establishment Year
Headquarters
Company type and size (global, regional; large, mid, small) Australia gene synthesis research-use revenue (AUD, latest year)
3-year Australia revenue CAGR
Share of revenue from research-use gene synthesis (%)
Average selling price per base pair / per construct
Average turnaround time (business days) by construct length
Australia Gene Synthesis Research Use Market Industry Analysis
Growth Drivers
Increasing Demand for Synthetic Biology Applications: The Australian synthetic biology market is projected to reach AUD 1.5 billion in future, driven by the rising demand for innovative solutions in healthcare, agriculture, and environmental sustainability. The biotechnology sector's contribution to the Australian economy is expected to grow by 5% in future, reflecting a robust interest in synthetic biology applications. This growth is supported by government initiatives aimed at fostering research and development in synthetic biology, enhancing the overall market landscape. Advancements in Gene Editing Technologies: The gene editing market in Australia is anticipated to expand significantly, with investments in CRISPR and other gene editing technologies projected to exceed AUD 300 million in future. These advancements are crucial for developing targeted therapies and improving crop resilience. The Australian government has allocated AUD 50 million to support research in gene editing, indicating a strong commitment to advancing these technologies and their applications in various sectors, including agriculture and medicine. Rising Investment in Biotechnology Research: In future, Australia's biotechnology sector is expected to receive over AUD 1 billion in funding, reflecting a growing interest from both public and private sectors. This investment is crucial for driving innovation in gene synthesis and related technologies. The Australian government has introduced several funding programs, including the Biomedical Translation Fund, which aims to support the commercialization of biotechnology research, thereby enhancing the market's growth potential and fostering a vibrant research ecosystem.
Market Challenges
High Costs Associated with Gene Synthesis: The cost of gene synthesis in Australia can range from AUD 500 to AUD 10,000 per gene, depending on complexity and length. These high costs pose a significant barrier for many research institutions and startups, limiting their ability to access advanced gene synthesis technologies. As a result, the market may experience slower growth, particularly among smaller entities that lack the financial resources to invest in these essential technologies. Regulatory Hurdles in Genetic Research: The regulatory landscape for genetic research in Australia is complex, with stringent guidelines governing gene editing and synthetic biology applications. Compliance with these regulations can lead to delays in research and development timelines, impacting the overall market growth. In future, it is estimated that compliance costs could account for up to 20% of total research budgets, creating additional challenges for researchers and companies operating in this space.
Australia Gene Synthesis Research Use Market Future Outlook
The future of the Australia gene synthesis research use market appears promising, driven by technological advancements and increasing applications across various sectors. The integration of artificial intelligence in gene synthesis processes is expected to enhance efficiency and accuracy, while the growing focus on personalized medicine will further stimulate demand. Additionally, collaborations between industry and academic institutions are likely to foster innovation, leading to new breakthroughs in gene synthesis technologies and applications, ultimately benefiting the healthcare and agricultural sectors.
Market Opportunities
Expansion of Personalized Medicine: The personalized medicine market in Australia is projected to reach AUD 2 billion in future, creating significant opportunities for gene synthesis applications. This growth is driven by advancements in genomics and the increasing demand for tailored therapies, which require precise gene synthesis technologies to develop effective treatments for individual patients. Collaborations with Academic Institutions: Partnerships between biotechnology companies and academic institutions are expected to increase, with over AUD 150 million allocated for collaborative research projects in future. These collaborations can enhance innovation in gene synthesis technologies, leading to the development of novel applications and solutions that address pressing challenges in healthcare and agriculture.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
The Australia Gene Synthesis Research Use Market is valued at approximately USD 120 million, based on a five-year historical analysis of the broader Australia gene synthesis market and its research-focused demand profile. This growth is primarily driven by advancements in biotechnology, increasing research activities in genomics, and the rising demand for synthetic biology applications, in line with global gene synthesis trends. The market has seen a surge in investments from both public and private sectors in areas such as synthetic biology, regenerative medicine, and genomics infrastructure, enhancing the capabilities and accessibility of gene synthesis technologies in Australia. Key players in this market are concentrated in major cities such as Sydney, Melbourne, and Brisbane. These cities dominate due to their robust research infrastructure, presence of leading academic institutions, and a thriving biotech industry, including hubs around the University of Sydney, UNSW Sydney, University of Melbourne, Monash University, and major medical research institutes. The collaboration between universities, Cooperative Research Centres, and biotech firms in these regions fosters innovation and accelerates the development and use of gene synthesis technologies in applications such as synthetic biology, therapeutics, and diagnostics. In 2023, the Australian government implemented the National Biotechnology Strategy, which aims to support the growth of the biotechnology sector, including gene synthesis, with a focus on strengthening sovereign capability and industry–research translation. This strategy includes funding initiatives and regulatory and policy frameworks designed to enhance research capabilities and promote collaboration between industry and academia, ultimately driving advancements in gene synthesis technologies. In parallel, activities in gene synthesis and related DNA technologies are governed by instruments such as the Gene Technology Act 2000 administered by the Office of the Gene Technology Regulator, which establishes licensing, risk assessment, and containment requirements for dealings with genetically modified organisms relevant to synthetic and engineered genetic material used in research.
Australia Gene Synthesis Research Use Market Segmentation
By Product & Service: The product and service segmentation of the market includes various offerings that cater to the diverse needs of researchers and organizations involved in gene synthesis. The subsegments include gene synthesis services, gene synthesis kits & reagents, gene fragments & oligonucleotides for research, GMP-grade gene synthesis for clinical research use, and others. This structure aligns with typical global gene synthesis offerings, where custom gene synthesis services, oligonucleotide products, and associated reagents form the core of the commercial portfolio. Among these, gene synthesis services are the most dominant due to their tailored solutions, increasing complexity of synthetic constructs, and high demand from academic and commercial research entities seeking outsourced, high-accuracy synthesis and design support. By Application: The application segmentation encompasses various fields where gene synthesis is utilized, including basic genetic & molecular biology research, synthetic biology & genome engineering, cell & gene therapy research, vaccine, antibody & protein engineering research, agricultural & industrial biotechnology research, and others. These application clusters are consistent with how global markets characterize demand for gene synthesis across research and preclinical domains. The cell & gene therapy research segment is currently leading the market due to the increasing focus on personalized medicine, engineered cell therapies, and nucleic-acid-based therapeutics, which require complex custom gene constructs and vector designs.
Australia Gene Synthesis Research Use Market Market Opportunities
The Australia Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as Integrated DNA Technologies (IDT), Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Eurofins Genomics, Twist Bioscience Corporation, Codex DNA / Telesis Bio, Bioneer Corporation, ATUM, GENEWIZ (Azenta Life Sciences), Bio Basic Inc., LGC Biosearch Technologies, Jena Bioscience GmbH, Genetic Signatures Ltd (Australia), Starpharma Holdings Limited (Australia), Agilent Technologies Inc. contribute to innovation, geographic expansion, and service delivery in this space.
Integrated DNA Technologies (IDT)
1987 Coralville, Iowa, USA
Thermo Fisher Scientific Inc. 2006 Waltham, Massachusetts, USA
GenScript Biotech Corporation
2002 Nanjing, China
Eurofins Genomics
2000 Luxembourg City, Luxembourg
Twist Bioscience Corporation
2013 San Francisco, California, USA
Company
Establishment Year
Headquarters
Company type and size (global, regional; large, mid, small) Australia gene synthesis research-use revenue (AUD, latest year)
3-year Australia revenue CAGR
Share of revenue from research-use gene synthesis (%)
Average selling price per base pair / per construct
Average turnaround time (business days) by construct length
Australia Gene Synthesis Research Use Market Industry Analysis
Growth Drivers
Increasing Demand for Synthetic Biology Applications: The Australian synthetic biology market is projected to reach AUD 1.5 billion in future, driven by the rising demand for innovative solutions in healthcare, agriculture, and environmental sustainability. The biotechnology sector's contribution to the Australian economy is expected to grow by 5% in future, reflecting a robust interest in synthetic biology applications. This growth is supported by government initiatives aimed at fostering research and development in synthetic biology, enhancing the overall market landscape. Advancements in Gene Editing Technologies: The gene editing market in Australia is anticipated to expand significantly, with investments in CRISPR and other gene editing technologies projected to exceed AUD 300 million in future. These advancements are crucial for developing targeted therapies and improving crop resilience. The Australian government has allocated AUD 50 million to support research in gene editing, indicating a strong commitment to advancing these technologies and their applications in various sectors, including agriculture and medicine. Rising Investment in Biotechnology Research: In future, Australia's biotechnology sector is expected to receive over AUD 1 billion in funding, reflecting a growing interest from both public and private sectors. This investment is crucial for driving innovation in gene synthesis and related technologies. The Australian government has introduced several funding programs, including the Biomedical Translation Fund, which aims to support the commercialization of biotechnology research, thereby enhancing the market's growth potential and fostering a vibrant research ecosystem.
Market Challenges
High Costs Associated with Gene Synthesis: The cost of gene synthesis in Australia can range from AUD 500 to AUD 10,000 per gene, depending on complexity and length. These high costs pose a significant barrier for many research institutions and startups, limiting their ability to access advanced gene synthesis technologies. As a result, the market may experience slower growth, particularly among smaller entities that lack the financial resources to invest in these essential technologies. Regulatory Hurdles in Genetic Research: The regulatory landscape for genetic research in Australia is complex, with stringent guidelines governing gene editing and synthetic biology applications. Compliance with these regulations can lead to delays in research and development timelines, impacting the overall market growth. In future, it is estimated that compliance costs could account for up to 20% of total research budgets, creating additional challenges for researchers and companies operating in this space.
Australia Gene Synthesis Research Use Market Future Outlook
The future of the Australia gene synthesis research use market appears promising, driven by technological advancements and increasing applications across various sectors. The integration of artificial intelligence in gene synthesis processes is expected to enhance efficiency and accuracy, while the growing focus on personalized medicine will further stimulate demand. Additionally, collaborations between industry and academic institutions are likely to foster innovation, leading to new breakthroughs in gene synthesis technologies and applications, ultimately benefiting the healthcare and agricultural sectors.
Market Opportunities
Expansion of Personalized Medicine: The personalized medicine market in Australia is projected to reach AUD 2 billion in future, creating significant opportunities for gene synthesis applications. This growth is driven by advancements in genomics and the increasing demand for tailored therapies, which require precise gene synthesis technologies to develop effective treatments for individual patients. Collaborations with Academic Institutions: Partnerships between biotechnology companies and academic institutions are expected to increase, with over AUD 150 million allocated for collaborative research projects in future. These collaborations can enhance innovation in gene synthesis technologies, leading to the development of novel applications and solutions that address pressing challenges in healthcare and agriculture.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Table of Contents
80 Pages
- 1. Australia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Overview
- 1.1. Definition and Scope
- 1.2. Market Taxonomy
- 1.3. Market Growth Rate
- 1.4. Market Segmentation Overview
- 2. Australia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Size (in USD Bn), 2019-2024
- 2.1. Historical Market Size
- 2.2. Year-on-Year Growth Analysis
- 2.3. Key Market Developments and Milestones
- 3. Australia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Analysis
- 3.1. Growth Drivers
- 3.1.1 Increasing demand for synthetic genes in pharmaceuticals
- 3.1.2 Advancements in gene editing technologies
- 3.1.3 Rising investments in biotechnology research
- 3.1.4 Growing applications in agricultural biotechnology
- 3.2. Restraints
- 3.2.1 High costs associated with gene synthesis
- 3.2.2 Regulatory challenges in genetic research
- 3.2.3 Limited awareness among potential users
- 3.2.4 Ethical concerns surrounding genetic modifications
- 3.3. Opportunities
- 3.3.1 Expansion of personalized medicine
- 3.3.2 Development of novel agricultural solutions
- 3.3.3 Collaborations between academia and industry
- 3.3.4 Increasing government funding for genetic research
- 3.4. Trends
- 3.4.1 Shift towards automation in gene synthesis
- 3.4.2 Growth of synthetic biology applications
- 3.4.3 Rising focus on sustainable biotechnology
- 3.4.4 Emergence of CRISPR technology in research
- 3.5. Government Regulation
- 3.5.1 Guidelines for genetic research and applications
- 3.5.2 Compliance requirements for biotechnology firms
- 3.5.3 Regulatory frameworks for gene editing technologies
- 3.5.4 Funding initiatives for genetic research projects
- 3.6. SWOT Analysis
- 3.7. Stakeholder Ecosystem
- 3.8. Competition Ecosystem
- 4. Australia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Segmentation, 2024
- 4.1. By Application Area (in Value %)
- 4.1.1 Pharmaceuticals
- 4.1.2 Agriculture
- 4.1.3 Research
- 4.1.4 Industrial Biotechnology
- 4.1.5 Others
- 4.2. By Technology Type (in Value %)
- 4.2.1 PCR-based Synthesis
- 4.2.2 Assembly-based Synthesis
- 4.2.3 Gene Editing Technologies
- 4.3. By End-User (in Value %)
- 4.3.1 Academic Institutions
- 4.3.2 Pharmaceutical Companies
- 4.3.3 Biotech Firms
- 4.4. By Service Type (in Value %)
- 4.4.1 Custom Gene Synthesis
- 4.4.2 Gene Assembly Services
- 4.4.3 Gene Editing Services
- 4.5. By Pricing Model (in Value %)
- 4.5.1 Fixed Pricing
- 4.5.2 Tiered Pricing
- 4.5.3 Subscription-based Pricing
- 4.6. By Region (in Value %)
- 4.6.1 New South Wales
- 4.6.2 Victoria
- 4.6.3 Queensland
- 4.6.4 Western Australia
- 4.6.5 South Australia
- 4.6.6 Tasmania
- 4.6.7 Australian Capital Territory
- 5. Australia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Cross Comparison
- 5.1. Detailed Profiles of Major Companies
- 5.1.1 GeneArt (Thermo Fisher Scientific)
- 5.1.2 Integrated DNA Technologies (IDT)
- 5.1.3 GenScript
- 5.1.4 Twist Bioscience
- 5.1.5 Synlogic
- 5.2. Cross Comparison Parameters
- 5.2.1 No. of Employees
- 5.2.2 Headquarters
- 5.2.3 Inception Year
- 5.2.4 Revenue
- 5.2.5 Production Capacity
- 6. Australia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Regulatory Framework
- 6.1. Biotechnology Standards
- 6.2. Compliance Requirements and Audits
- 6.3. Certification Processes
- 7. Australia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Future Size (in USD Bn), 2025-2030
- 7.1. Future Market Size Projections
- 7.2. Key Factors Driving Future Market Growth
- 8. Australia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Future Segmentation, 2030
- 8.1. By Application Area (in Value %)
- 8.2. By Technology Type (in Value %)
- 8.3. By End-User (in Value %)
- 8.4. By Service Type (in Value %)
- 8.5. By Pricing Model (in Value %)
- 8.6. By Region (in Value %)
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
